CURE Pharmaceutical (CURR) Stock Skyrockets Amid Wellness Pivot – What’s Next for Investors?
CURE Pharmaceutical, now Avenir Wellness Solutions (AVRW), closed at $3.78 on Oct. 31, up 30.8% in one day and more than doubling over two weeks. The rally follows a settlement converting major debt to equity and anticipation of Nov. 18 earnings. The company rebranded in 2023 and focuses on wellness products. Technical signals warn of high volatility and potential pullback after the surge.
